Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Barton Peter Hutt


  • Director at Moderna Inc. (MRNA), 2019-11-22
  • Director at Concert Pharmaceuticals Inc. (CNCE), 2019-08-12
  • Director at Immunomedics Inc (IMMU), 2019-06-11
  • Director at Flex Pharma Inc. (FLKS), 2018-07-26
  • Director at Selecta Biosciences Inc (SELB), 2018-06-19
  • Director at Xoma Corp (XOMA), 2017-05-22
  • Director at Dnib Unwind Inc. (BIND), 2016-08-30
  • Director at Seres Therapeutics Inc. (MCRB), 2016-06-17
  • Director at Q Therapeutics Inc. ([NONE]), 2014-12-22
  • Director at Momenta Pharmaceuticals Inc (MNTA), 2014-09-15
  • Director at Ista Pharmaceuticals Inc (ISTA), 2012-06-15
  • Director at Celera Corp (CRA), 2011-05-19
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRNA $20.18 200,000 Director 3,924 2019-11-20 Filing
MRNA $17.63 100,000 Director 3,924 2019-09-17 Filing
CNCE $10.31 3,539 Director 4,424 2019-08-08 Filing
CNCE $9.81 22,123 Director 0 2016-11-14 Filing
MNTA $11.42 3,640 Director 6,725 2014-09-12 Filing